Azithromycin is not recommended as a treatment for COVID-19. Multiple large clinical trials found no benefit for patients with COVID-19, and major medical organizations, including the Infectious Diseases Society of America, explicitly advise against its use for this purpose. While azithromycin is generally a safe antibiotic when prescribed for bacterial infections, taking it for a viral illness like COVID-19 exposes you to real risks with no upside.
Why Azithromycin Was Tried for COVID-19
Early in the pandemic, there were plausible reasons to think azithromycin might help. Beyond killing bacteria, macrolide antibiotics like azithromycin have immunomodulatory properties, meaning they can dial down excessive inflammation without completely suppressing the immune system. Since severe COVID-19 often involved a dangerous overreaction of the immune system that damaged the lungs and other organs, researchers hypothesized that azithromycin could help correct that imbalance.
This hypothesis was tested in rigorous clinical trials. The results were clear: azithromycin did not improve outcomes for COVID-19 patients, whether they had mild, moderate, or severe disease. It didn’t reduce hospitalizations, shorten recovery time, or lower the risk of death. The theoretical anti-inflammatory benefit simply didn’t translate into a real-world effect against this virus.
Heart Rhythm Risks Are Real
Taking azithromycin when it isn’t needed carries specific cardiac risks that matter. The drug can disrupt the electrical timing of your heartbeat, a problem called QT prolongation. In some cases, this leads to dangerous irregular heart rhythms.
An analysis of the World Health Organization’s global safety database found that azithromycin was associated with a higher rate of dangerous heart rhythm events than many people realize. About 0.8% of azithromycin-related adverse event reports involved prolonged QT intervals or dangerous ventricular arrhythmias, more than double the rate seen with hydroxychloroquine (0.3%). The onset was fast, too: heart rhythm problems with azithromycin appeared at a median of just 3 days after starting the drug. Among those who developed the most serious arrhythmia type (torsades de pointes), roughly 20% of azithromycin cases resulted in death.
These risks are especially concerning if you’re also taking other medications that affect heart rhythm or if you have an existing heart condition. During the early pandemic, many patients received azithromycin alongside hydroxychloroquine, a combination that roughly doubled the reporting rate of serious cardiac events compared to either drug alone.
Common Side Effects
Even setting aside the cardiac concerns, azithromycin frequently causes gastrointestinal problems. Studies estimate that roughly 1 in 4 people who take it experience some form of digestive side effect. Diarrhea is the most common, followed by constipation, bloating, vomiting, and abdominal pain. These side effects are tolerable when the antibiotic is treating a real bacterial infection, but they’re an unnecessary burden when the drug provides no benefit against a virus.
The Antibiotic Resistance Problem
One of the lasting consequences of widespread azithromycin use during the pandemic is its contribution to antibiotic resistance. The CDC documented that azithromycin was the most commonly prescribed antibiotic for adults with COVID-19, and prescribing surges tracked directly with waves of COVID-19 cases. In nursing homes, azithromycin use was 150% higher in April 2020 and 82% higher in December 2020 compared to the same months the year before. In hospitals, roughly half of admitted COVID-19 patients received an antibiotic regimen that included azithromycin.
Every unnecessary course of antibiotics gives bacteria more opportunities to develop resistance. This means that when you or someone else genuinely needs azithromycin for a bacterial infection in the future, it may be less effective. Taking azithromycin for COVID-19 doesn’t just fail to help you individually; it contributes to a broader public health problem.
When Antibiotics Do Make Sense With COVID-19
There is one scenario where azithromycin during a COVID-19 infection can be appropriate: when you develop a secondary bacterial infection on top of the viral illness. COVID-19 can damage the lining of your airways and weaken local immune defenses, creating conditions where bacteria can take hold. Bacterial pneumonia is the most common example.
The IDSA guidelines make this distinction clearly. Their recommendation against azithromycin for COVID-19 specifically does not apply to cases of secondary bacterial pneumonia. If your doctor identifies signs of a bacterial infection, such as a new fever after initial improvement, worsening cough with changes in mucus, or lab results pointing to bacterial involvement, prescribing an antibiotic like azithromycin is a separate clinical decision based on the bacterial infection, not the virus itself.
Pregnancy Considerations
For pregnant individuals wondering about azithromycin safety more broadly, the available evidence is reassuring. Most studies have not found an increased risk of birth defects, miscarriage, or preterm delivery with azithromycin exposure during pregnancy. One study flagged possible associations with specific heart defects, but those findings were likely influenced by study design limitations rather than a true causal link. Erythromycin has traditionally been preferred during pregnancy simply because it has a longer track record, though treatment decisions depend on the specific situation. None of this changes the core point: azithromycin still should not be used to treat COVID-19 itself, regardless of pregnancy status.
What Actually Works for COVID-19
If you’re looking for effective COVID-19 treatment, the landscape has changed significantly since the early pandemic. Antiviral medications that directly target the virus are now available for people at higher risk of severe illness. These work best when started within the first few days of symptoms. Supportive care, including rest, fluids, and over-the-counter medications for fever and pain, remains the foundation for most mild cases. Vaccination continues to be the most effective way to reduce the risk of severe outcomes.
If someone has prescribed or suggested azithromycin specifically to treat your COVID-19 infection, it’s worth asking whether there’s evidence of a bacterial co-infection. Without that, the antibiotic carries risk with no demonstrated reward.